CIK 1802967
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2025-Q4. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Pharmaceuticals & Biotechnology | 42.40% | 2 |
| Automobiles & Components | 26.98% | 1 |
| Machinery | 13.07% | 1 |
| Hotels, Restaurants & Leisure | 8.47% | 1 |
| Life Sciences Tools & Services | 3.77% | 1 |
| Technology Hardware & Equipment | 2.93% | 1 |
| Health Care Equipment & Supplies | 2.38% | 1 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | TWST | Twist Bioscience Corp | Health Care | 33.14% |
| 2 | TSLA | Tesla, Inc. | Consumer Discretionary | 26.98% |
| 3 | OUST | Ouster, Inc. | Industrials | 13.07% |
| 4 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Health Care | 9.25% |
| 5 | H | Hyatt Hotels Corp | Consumer Discretionary | 8.47% |
| 6 | TXG | 10x Genomics, Inc. | Health Care | 3.77% |
| 7 | MASS | 908 Devices Inc. | Information Technology | 2.93% |
| 8 | WRBY | Warby Parker Inc. | Health Care | 2.38% |
8/8 names classified · sector 100.0% of weight · industry 100.0% · mkt cap 100.0%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 100.0% of the book is sector-classified (unclassified names shown, never dropped).
Only 41% of book weight classified — the grid is NOT representative of the whole book.
Classified: 40.8% of book weight (4/8 names) · unclassified 59.2%: TWST, OUST, MDGL, TXG. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| # | Security | Shares | Value | Weight | Δ QoQ |
|---|---|---|---|---|---|
| 1 | TWSTTWIST BIOSCIENCE CORP | 828,815 | $39M | 33.1% | HOLD |
| 2 | TSLATESLA INC | 86,250 | $32M | 27.0% | HOLD |
| 3 | OUSTOUSTER INC | 845,316 | $16M | 13.1% | HOLD |
| 4 | MDGLMADRIGAL PHARMACEUTICALS INC | 21,000 | $11M | 9.3% | HOLD |
| 5 | HHYATT HOTELS CORP | 70,000 | $10M | 8.5% | HOLD |
| 6 | TXG10X GENOMICS INC | 210,862 | $4M | 3.8% | HOLD |
| 7 | MASS908 DEVICES INC | 568,981 | $3M | 2.9% | HOLD |
| 8 | WRBYWARBY PARKER INC | 134,473 | $3M | 2.4% | HOLD |
| Security | 2024-Q4 | 2025-Q1 | 2025-Q2 | 2025-Q3 | 2025-Q4 | 2026-Q1 | Latest value |
|---|---|---|---|---|---|---|---|
| TWSTTWIST BIOSCIENCE CORP | 829K | 829K | 829K | 829K | 829K | 829K | $39M |
| TSLATESLA INC | 86K | 86K | 86K | 86K | 86K | 86K | $32M |
| OUSTOUSTER INC | 1.1M | 1.1M | 1.1M | 1.1M | 845K | 845K | $16M |
| MDGLMADRIGAL PHARMACEUTICALS INC | 131K | 113K | 113K | 41K | 21K | 21K | $11M |
| HHYATT HOTELS CORP | 70K | 70K | 70K | 70K | 70K | 70K | $10M |
| TXG10X GENOMICS INC | — | — | — | 211K | 211K | 211K | $4M |
| MASS908 DEVICES INC | 569K | 569K | 569K | 569K | 569K | 569K | $3M |
| WRBYWARBY PARKER INC | 134K | 134K | 134K | 134K | 134K | 134K | $3M |
Shares reported each quarter by the largest current holdings. Green = added vs the prior filing of that name, red = trimmed, grey = roughly held; a dash is a quarter with no 13F on file (a gap is skipped, not read as an exit). 13F is filed up to 45 days after quarter-end. Up to 40 quarters (10 years) available — use the selector above.
Where this firm's principals came from and which firms its alumni went on to found.
